|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3850 AUD | +5.48% |
|
+2.67% | -40.77% |
| Market Cap | 109M 76.5M 66.89M 61.7M 56.72M 107M 7.36B 737M 289M 3.6B 287M 281M 12.4B | P/E 2026 * |
-6.08x | P/E 2027 * | -2.28x |
|---|---|---|---|---|---|
| Enterprise Value | 117M 82.15M 71.82M 66.26M 60.91M 115M 7.9B 791M 310M 3.86B 309M 302M 13.32B | EV / Sales 2026 * |
12.3x | EV / Sales 2027 * | 20x |
| Free-Float |
60.61% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +5.48% | ||
| 1 week | +2.67% | ||
| Current month | -4.94% | ||
| 1 month | -22.22% | ||
| 3 months | -31.25% | ||
| 6 months | -45.00% | ||
| Current year | -40.77% |
| 1 week | 0.36 |  | 0.39 |
| 1 month | 0.36 | | 0.51 |
| Current year | 0.36 | | 0.73 |
| 1 year | 0.34 | | 0.73 |
| 3 years | 0.28 | | 0.78 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 28/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 01/10/2012 |
James Graham
BRD | Director/Board Member | - | 01/05/2012 |
| Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/02 | Expiration | Chief Executive Officer | 2,250,000 | 0.7781% | ||
| 14/10/25 | Expiration | Chief Executive Officer | 745,962 | 0.3217% | ||
| 21/11/24 | Buy | Director | 1,000,000 | 0.4313% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.48% | +2.67% | +14.93% | -39.84% | 76.5M | |
| +0.35% | -4.87% | +49.87% | +157.34% | 1,031B | |
| -2.69% | -6.22% | +59.19% | +54.51% | 595B | |
| -0.27% | -3.41% | +30.97% | +79.48% | 431B | |
| -0.45% | -1.91% | +28.45% | +22.71% | 326B | |
| -0.17% | -2.06% | +27.99% | +43.36% | 277B | |
| -0.94% | -6.80% | +19.26% | +22.02% | 263B | |
| +1.00% | +4.64% | -22.58% | -37.37% | 224B | |
| +0.86% | -2.63% | +22.50% | +57.55% | 193B | |
| +1.28% | -3.03% | +20.76% | +70.62% | 164B | |
| Average | +0.44% | -3.68% | +25.13% | +43.04% | 350.44B | |
| Weighted average by Cap. | -0.34% | -4.31% | +35.61% | +76.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.56M 6.69M 5.85M 5.4M 4.96M 9.4M 644M 64.41M 25.27M 315M 25.12M 24.57M 1.08B | 8.19M 5.73M 5.01M 4.62M 4.25M 8.05M 552M 55.2M 21.66M 270M 21.53M 21.06M 929M |
| Net income | -18.68M -13.08M -11.43M -10.55M -9.7M -18.37M -1.26B -126M -49.41M -615M -49.11M -48.03M -2.12B | -47.2M -33.03M -28.88M -26.64M -24.49M -46.4M -3.18B -318M -125M -1.55B -124M -121M -5.35B |
| Net Debt | 8.07M 5.65M 4.94M 4.56M 4.19M 7.93M 543M 54.38M 21.34M 266M 21.21M 20.75M 916M | 54.63M 38.23M 33.43M 30.84M 28.35M 53.71M 3.68B 368M 144M 1.8B 144M 140M 6.2B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | $0.3850 | +5.48% | 195,033 |
| 15/07/26 | $0.3650 | -5.19% | 150,075 |
| 14/07/26 | $0.3850 | -1.28% | 406,483 |
| 13/07/26 | $0.3900 | +1.30% | 354,511 |
| 10/07/26 | $0.3850 | +2.67% | 137,951 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
